Toxicological aspects and health risks associated with hydroquinone in skin-bleaching formulae;Toxicologische aspecten en gezondheidsrisico's van hydrochinon in huidbleekformuleringen

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 16, 2004, Pages 768-771

  Kooyers, T J ^a,b   Westerhof, W ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Nutri Pharma ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; BLEACHING AGENT; COSMETIC; HYDROQUINONE; THIOCTIC ACID;

BLEACHING; CANCER; CARCINOGENICITY; DNA DAMAGE; DRUG ABSORPTION; DRUG EXCRETION; HEALTH HAZARD; HUMAN; KIDNEY ADENOMA; LEUKEMIA; LEUKODERMA; NEPHROTOXICITY; OCHRONOSIS; REVIEW;

ADMINISTRATION, TOPICAL; COSMETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; FACE; HUMANS; HYDROQUINONES; HYPERPIGMENTATION; OCHRONOSIS; SKIN;

EID: 1842831325     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Vierentwintigste richtlijn 2000/6/EG. Publicatieblad van de Europese Gemeenschappen 2000;L56:42-6.
2. Menke HE, Gomes PD, Lamur H, Westerhof W. Een tintje lichter. Med Contact 2001;56:89-91.
3. Snyder R, Hedli CC. An overview of benzene metabolism. Environ Health Perspect 1996;104(Suppl 6):1165-71.
4. Environmental Health Criteria 157. Hydroquinone. Genève: WHO; 1994.
5. Rao GS. Glutathionyl hydroquinone: a potent pro-oxidant and a possible toxic metabolite of benzene. Toxicology 1996;106:49-54.
6. Kooyers TJ. Hydrochinon, het middel erger dan de kwaal [afstudeerverslag]? Heerlen: Open Universiteit; 2002.
7. Gomes PD, Westerhof W. Het gebruik van chemische huidbleek-middelen onder Ghanese vrouwen in Amsterdam-Zuidoost. Aanzet tot onderzoek en discussie. Tijdschr Genderstudies 2001;4:20-33.
8. Wester RC, Melendres J, Hui X, Cox R, Serranzana S, Zhai H, et al. Human in vivo and in vitro hydroquinone topical bioavailability metabolism, and disposition. J Toxicol Environ Health A 1998;54:301-17.
9. Corley RA, English JC, Hill TS, Fiorica LA, Morgott DA. Development of a physiologically based pharmacokinetic model for hydroquinone. Toxicol Appl Pharmacol 2000;165:163-75.
10. 3FI mice (gavage studies). National Toxicology program. NIH publication 90-2821. Washington: Department of Health and Human Services; 1989.
11. Shibata MA, Hirose M, Tanaka H, Asakawa E, Shirai T, Ino N. Induction of renal cell tumors in rats and mice, and enhancement of hepatocellular tumor development in mice after long-term hydroquinone treatment. Jpn J Cancer Res 1991;82:1211-9.
12. Lau SS, Monks TJ, Everitt JI, Kleymenova E, Walker CL. Carcinogenity of a nephrotoxic metabolite of the 'nongenotoxic' carcinogen hydroquinone. Chem Res Toxicol 2001;14:25-33.
13. Hahn WC, Weinberg RA. Modelling the molecular circuitry of cancer. Nat Rev Cancer 2002;2:331-41.
14. 19-bone marrow cells. Exp Hematol 2000;28:169-76.
15. Sze CC, Shi CY, Ong CN. Cytotoxicity and DNA strand breaks induced by benzene and its metabolites in Chinese hamster ovary cells. J Appl Toxicol 1996;16:259-64.
16. Joseph P, Klein-Szanto AJP, Jaiswal AK. Hydroquinones cause specific mutations and lead to cellular transformation and in vivo tumorigenesis. Br J Cancer 1998;78:312-20.
17. Lee EW, Garner CD. Effects of benzene on DNA strand breaks in vivo versus benzene metabolite-induced DNA strand breaks in vitro in mouse bone marrow cells. Toxicol Appl Pharmacol 1991;108:497-508.
18. Kuo ML, Shiah SG, Wang CJ, Chuang SE. Suppression of apoptosis by Bcl-2 to enhance benzene metabolites induced oxidative DNA damage and mutagenesis: a possible mechanism of carcinogenesis. Mol Pharmacol 1999;55:894-901.
19. Levin CY, Maibach H. Exogenous ochronosis. An update on clinical features, causative agents and treatment options. Am J Clin Dermatol 2001;2:213-7.
20. Shen Y, Shen HM, Shi CY, Ong CN. Benzene metabolites enhance reactive oxygen species generation in HL6o human leukemia cells. Hum Exp Toxicol 1996;15:422-7.
21. Do Ceu Silva M, Gaspar J, Silva ID, Leao D, Rueff J. Mechanisms of induction of chromosomal aberrations by hydroquinone in V79 cells. Mutagenesis 2003;18:491-6.
22. Yin SN, Hayes RB, Linet MS, Li G, Dosemeci M, Travis LB, et al. An expanded cohort study of cancer among benzene-exposed workers in China. Benzene Study Group. Environ Health Perspect 1996;104 Suppl 6:1339-41.
23. Briganti S, Camera E, Picardo M. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 2003;16:101-10.